MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01251cam a2200217 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
4431550305 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
161207t2016 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
4431550305 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9784431550303 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Yamaguchi, Yoshiyuki (ed) |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Immunotherapy of cancer |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Tokyo : |
| Name of publisher, distributor, etc. |
Springer, |
| Date of publication, distribution, etc. |
2016 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Overview, history, classification; BRMs and crude agents; Adoptive cell therapy; Vaccine therapy; Immunoadjuvants; Immunocheckpoints; Regulation of immunosuppression; Immune-related response criteria and guidance for clinical trials; Personalized immunotherapy |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer - Immunotherapy |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunology |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Immunology |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Immunotherapy |
| 9 (RLIN) |
6577 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Cancer |